NYSE:BHVNBiotechs
Are Biohaven (BHVN) Lawsuit Allegations a Test of Management Transparency and Investor Trust?
Pomerantz LLP announced that a class action lawsuit was filed in the United States District Court for the District of Connecticut against Biohaven Ltd. and certain officers, alleging violations of federal securities laws between March 24, 2023 and May 14, 2025.
This legal action brings renewed scrutiny to Biohaven’s leadership and disclosure practices, raising questions about potential impacts on stakeholder confidence.
We’ll examine how these legal challenges could influence Biohaven’s...